Personal tools

MCL coexpression mm9:2566: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002020!2.01e-17!34;UBERON:0003056!3.00e-17!49;UBERON:0010371!6.45e-17!73;UBERON:0002346!1.93e-16!64;UBERON:0003075!1.93e-16!64;UBERON:0007284!1.93e-16!64;UBERON:0000073!3.45e-16!54;UBERON:0003528!3.67e-16!29;UBERON:0002791!3.67e-16!29;UBERON:0001893!3.67e-16!29;UBERON:0004121!6.33e-16!95;UBERON:0000924!6.33e-16!95;UBERON:0006601!6.33e-16!95;UBERON:0001049!9.47e-16!52;UBERON:0005068!9.47e-16!52;UBERON:0006241!9.47e-16!52;UBERON:0007135!9.47e-16!52;UBERON:0003080!6.45e-15!40;UBERON:0000955!1.51e-14!47;UBERON:0006238!1.51e-14!47;UBERON:0002780!2.11e-14!39;UBERON:0001890!2.11e-14!39;UBERON:0006240!2.11e-14!39;UBERON:0002616!3.97e-14!46;UBERON:0001017!5.22e-14!73;UBERON:0000956!1.72e-13!21;UBERON:0001869!1.72e-13!21;UBERON:0000203!1.72e-13!21;UBERON:0001016!2.10e-13!75;UBERON:0002619!6.14e-11!17;UBERON:0010314!9.72e-11!92;UBERON:0002021!9.43e-08!10;UBERON:0000411!9.43e-08!10;UBERON:0001950!9.43e-08!10;UBERON:0000025!3.99e-07!114;UBERON:0004111!6.39e-07!122
|ontology_enrichment_uberon=UBERON:0002020!2.01e-17!34;UBERON:0003056!3.00e-17!49;UBERON:0010371!6.45e-17!73;UBERON:0002346!1.93e-16!64;UBERON:0003075!1.93e-16!64;UBERON:0007284!1.93e-16!64;UBERON:0000073!3.45e-16!54;UBERON:0003528!3.67e-16!29;UBERON:0002791!3.67e-16!29;UBERON:0001893!3.67e-16!29;UBERON:0004121!6.33e-16!95;UBERON:0000924!6.33e-16!95;UBERON:0006601!6.33e-16!95;UBERON:0001049!9.47e-16!52;UBERON:0005068!9.47e-16!52;UBERON:0006241!9.47e-16!52;UBERON:0007135!9.47e-16!52;UBERON:0003080!6.45e-15!40;UBERON:0000955!1.51e-14!47;UBERON:0006238!1.51e-14!47;UBERON:0002780!2.11e-14!39;UBERON:0001890!2.11e-14!39;UBERON:0006240!2.11e-14!39;UBERON:0002616!3.97e-14!46;UBERON:0001017!5.22e-14!73;UBERON:0000956!1.72e-13!21;UBERON:0001869!1.72e-13!21;UBERON:0000203!1.72e-13!21;UBERON:0001016!2.10e-13!75;UBERON:0002619!6.14e-11!17;UBERON:0010314!9.72e-11!92;UBERON:0002021!9.43e-08!10;UBERON:0000411!9.43e-08!10;UBERON:0001950!9.43e-08!10;UBERON:0000025!3.99e-07!114;UBERON:0004111!6.39e-07!122
|tfbs_overrepresentation_for_novel_motifs=0.752782,0.564138,0.722405,0.801166,0.587814,0.81763,0.919454,0.467321,0.479531,0.235304,0.870507,0.906098,0.467629,0.933025,0.608226,0,1.14208,1.41496,0.448066,0.876292,0.679146,0.275782,0.932027,0.585919,0.731217,0.963352,0.437236,0.841386,0.64294,0.99159,0.825437,1.24901,0.575271,0.411696,0.608816,0.872889,0.563758,0.902078,0.536514,0.50014,0.582863,0.831295,0.261619,0.610669,0.922882,0.788421,1.05665,0.859154,0.235354,0.646474,1.12346,0.99279,0.371606,1.3966,1.41464,0.940919,0.657156,0.891887,1.91135,0.938668,1.22795,1.00308,0.494668,1.11142,0.953187,1.15459,1.55483,1.90983,1.22303,1.7608,0.700291,1.19585,0.284975,1.44925,0.416814,0.402065,0.411601,1.04436,1.20986,0.684144,0.476502,1.16055,1.00151,1.16164,1.32978,0.181575,0.195254,0.99201,1.06194,2.07346,1.62608,1.33496,1.26245,0.595071,0.531443,0.509215,1.17262,1.26539,1.05692,0.352122,0.563856,1.24872,1.37854,1.12409,1.12297,0.830796,1.18646,0.854628,0.689894,0.681267,0.744607,1.38039,0.685481,0.876299,1.63327,0.580657,0.609576,1.88801,1.14346,0.559153,1.45481,1.08896,0.965352,1.04338,1.68841,1.21376,0.928483,1.25534,1.55328,0.598722,1.36093,0.792832,1.52297,0.955954,1.65529,0.273451,0.762499,0.832891,1.60513,2.44352,2.04137,1.55966,0.978551,1.26,1.11604,0.831808,1.06002,2.40374,0.765221,0.589976,0.999018,1.32874,1.39822,0.516739,0.954936,1.48249,0.993889,0.622823,1.77347,0.762177,1.61484,1.32889,1.21423,0.741984,1.11251,0.94678,1.38188,0.904334,0.135528
}}
}}

Revision as of 21:36, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:58275107..58275157,+p@chr10:58275107..58275157
+
Mm9::chr10:58275314..58275348,+p@chr10:58275314..58275348
+
Mm9::chr12:50484072..50484092,+p4@Foxg1


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
CNS neuron (sensu Vertebrata)6.43e-0823
neuroblast (sensu Vertebrata)6.43e-0823
electrically responsive cell2.63e-0739
electrically active cell2.63e-0739

Uber Anatomy
Ontology termp-valuen
gray matter2.01e-1734
pre-chordal neural plate3.00e-1749
ecto-epithelium6.45e-1773
neurectoderm1.93e-1664
neural plate1.93e-1664
presumptive neural plate1.93e-1664
regional part of nervous system3.45e-1654
brain grey matter3.67e-1629
regional part of telencephalon3.67e-1629
telencephalon3.67e-1629
ectoderm-derived structure6.33e-1695
ectoderm6.33e-1695
presumptive ectoderm6.33e-1695
neural tube9.47e-1652
neural rod9.47e-1652
future spinal cord9.47e-1652
neural keel9.47e-1652
anterior neural tube6.45e-1540
brain1.51e-1447
future brain1.51e-1447
regional part of forebrain2.11e-1439
forebrain2.11e-1439
future forebrain2.11e-1439
regional part of brain3.97e-1446
central nervous system5.22e-1473
cerebral cortex1.72e-1321
cerebral hemisphere1.72e-1321
pallium1.72e-1321
nervous system2.10e-1375
regional part of cerebral cortex6.14e-1117
structure with developmental contribution from neural crest9.72e-1192
occipital lobe9.43e-0810
visual cortex9.43e-0810
neocortex9.43e-0810
tube3.99e-07114
anatomical conduit6.39e-07122


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}